Dendreon Announces Data Presentation at the 2012 American Urological ... - MarketWatch (press release)

Dendreon Announces Data Presentation at the 2012 American Urological ... MarketWatch (press release) "Sipuleucel-T in African Americans: A Subgroup Analysis of Three Phase 3 Trials of Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer," abstract #953. Moderated Poster Session, Prostate Cancer: Advanced III from 10:30 am to 12:30 pm ET on ... What You Must Know Before Investing in Prostate Cancer StocksMinyanville.com all 11 news articles »

Studies Reveal New Prostate Cancer Mutation Profiles, Subtypes - GenomeWeb

New York Daily News

Studies Reveal New Prostate Cancer Mutation Profiles, Subtypes GenomeWeb "Our integrated, exome-based profiling of the mutational landscape of [castration-resistant prostate cancer] is notable for representing a large cohort of heavily pre-treated patients with lethal metastatic disease, which are not commonly studied," ... Discovery Of New Prostate Cancer Mutation Could Make Treatment More EffectiveThe Inquisitr all 20 news articles »